Ryan P. Knox

Nov 22, 2023 | jamanetwork.com | Ryan P. Knox |Junyi Wang |William B. Feldman |Aaron S. Kesselheim

Key PointsQuestion  How has the 340B Drug Pricing Program affected the US health care system? Findings  This scoping review found evidence that the 340B program was associated with revenue to hospitals, clinics, and pharmacies; expanded services for patients; and costs to pharmaceutical manufacturers. The study found mixed evidence that 340B revenue funded health care specifically for low-income populations.